77 results
S-1/A
EX-10.4
RPHM
Reneo Pharmaceuticals Inc
5 Apr 21
IPO registration (amended)
9:12am
; and
c. Section 8(c) regarding the tax consequences of your Option.
Your Option is further subject to all interpretations, amendments, rules … , be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then any such 280G Payment (a “Payment”) shall be equal to the Reduced
S-1/A
EX-10.5
RPHM
Reneo Pharmaceuticals Inc
5 Apr 21
IPO registration (amended)
9:12am
Continuous Service notwithstanding the grant of the RSU Award; and
c. Section 8(c) of the Plan regarding the tax consequences of your RSU Award.
Your … , and (ii) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then any such 280G Payment
S-1
EX-10.10
RPHM
Reneo Pharmaceuticals Inc
19 Mar 21
IPO registration
5:27pm
, then the Executive shall have the right to request that a portion of the award be paid in cash in an amount that is sufficient to satisfy the Company’s tax … to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment will be equal to the Reduced Amount (defined below). The “Reduced
S-1
EX-10.12
RPHM
Reneo Pharmaceuticals Inc
19 Mar 21
IPO registration
5:27pm
) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment will be equal … of the Payment (after reduction) being subject to the Excise Tax or (2) the entire Payment, whichever amount after taking into account all applicable federal
S-1
EX-10.15
RPHM
Reneo Pharmaceuticals Inc
19 Mar 21
IPO registration
5:27pm
”) would (i) constitute a “parachute payment” within the meaning of Section 280G of the Code, and (ii) but for this sentence, be subject to the excise tax … imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment will be equal to the Reduced Amount (defined below). The “Reduced Amount
S-1
EX-10.13
b8h6ocyrxiiwqqwd08j
19 Mar 21
IPO registration
5:27pm
S-1
EX-10.14
koqohn64g1
19 Mar 21
IPO registration
5:27pm
S-1/A
EX-10.15
4g3mi
5 Apr 21
IPO registration (amended)
9:12am
424B5
0xrv64lqvfbkjm
3 May 23
Prospectus supplement for primary offering
4:20pm
S-1
EX-10.2
xtxo 4bprgn
19 Mar 21
IPO registration
5:27pm
S-1/A
EX-10.1
iwjp0ryap4afiqxov1
5 Apr 21
IPO registration (amended)
9:12am
424B5
5rt pkmtmf8j
4 May 23
Prospectus supplement for primary offering
5:15pm
S-1/A
EX-10.6
musfb
5 Apr 21
IPO registration (amended)
9:12am
S-8
EX-99.6
v6f v9p9fdtu57nj3h9
8 Apr 21
Registration of securities for employees
9:44pm
8-K
EX-10.6
dw74vo8a3vipa
13 May 24
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
9:14am
S-1/A
EX-10.9
218mm 7s4
5 Apr 21
IPO registration (amended)
9:12am